Conformationally Restricted Analogues of Psorospermin:  Design, Synthesis, and Bioactivity of Natural-Product-Related Bisfuranoxanthones

The antileukemic xanthone psorospermin is a topoisomerase II−dependent DNA alkylator in advanced preclinical development. Efforts have been made to further understand the structural requirements of its mechanism of action through the synthesis of ring-constrained analogues, based on the skeleton of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2005-04, Vol.48 (8), p.2993-3004
Hauptverfasser: Heald, Robert A, Dexheimer, Thomas S, Vankayalapati, Hariprasad, Siddiqui-Jain, Adam, Szabo, Lajos Z, Gleason-Guzman, Mary C, Hurley, Laurence H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3004
container_issue 8
container_start_page 2993
container_title Journal of medicinal chemistry
container_volume 48
creator Heald, Robert A
Dexheimer, Thomas S
Vankayalapati, Hariprasad
Siddiqui-Jain, Adam
Szabo, Lajos Z
Gleason-Guzman, Mary C
Hurley, Laurence H
description The antileukemic xanthone psorospermin is a topoisomerase II−dependent DNA alkylator in advanced preclinical development. Efforts have been made to further understand the structural requirements of its mechanism of action through the synthesis of ring-constrained analogues, based on the skeleton of the bisfuranoxanthone natural products. Molecules were designed that contain the bisfuran and xanthone portions of naturally occurring psorofebrins, and molecular modeling was used to assess their DNA alkylating potential and to refine the structures. A short, diastereoselective synthetic process to access bisfuranoxanthones was developed, culminating in the first total synthesis of (±)-isohydroxypsorofebrin. Two compounds designed and synthesized were of particular interest, chlorohydrin 7 and epoxide 6, which are reactive analogues of the natural product isohydroxypsorofebrin. The chlorohydrin retains the psorospermin-like DNA alkylation characteristics despite its rigid structure and high innate affinity for DNA. Molecular modeling has been used to rationalize the increased activity of the chlorohydrin. The chlorohydrin and epoxide show increased cytotoxicity compared to isohydroxypsorofebrin against a range of human tumor cell lines.
doi_str_mv 10.1021/jm049299c
format Article
fullrecord <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_jm049299c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_TPS_2VGPQS6W_Z</sourcerecordid><originalsourceid>FETCH-LOGICAL-a381t-193a92135df14408f637d22e3293291f9054688e54a35d0168b50d798e4843da3</originalsourceid><addsrcrecordid>eNptkc9O3DAQxq2qqGyBQ1-gyqWHSqT1vyR2b7AtFAmVhaWt1Is1JDb1ksQr20HsjSs8Jk-CV7tiL0gjzcjzm0-ebxD6QPAXgin5Ouswl1TK-g0akYLinAvM36IRxpTmtKRsG70PYYYxZoSyd2ibFIIKwcQIPY5db5zvIFrXQ9susgsdord11E12kF7c9aBD5kw2Cc67MNe-s_23p_uH7LsO9rrfz6aLPv5PddjPoG-yQ-ugjvbWxsVy7BfEwUObT7xrhjrmF7qFpfahDSY1encHadz1OuyiLQNt0HvrvIN-H_24HP_MT8-OT8YHpzkwQWJOJANJCSsaQzjHwpSsaijVjMoUxEhc8FIIXXBIDCaluCpwU0mhueCsAbaDPq9067RP8Nqoubcd-IUiWC39VC9-Jvbjip0PV51uNuTawAR8WgMQamhN2qi2YcOVFce0kInLV5wNUd-99MHfqLJiVaEuJ1NF_xxPzqflX_Vvowt1UDM3-HSK8MoHnwEq4ZsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Conformationally Restricted Analogues of Psorospermin:  Design, Synthesis, and Bioactivity of Natural-Product-Related Bisfuranoxanthones</title><source>ACS Publications</source><source>MEDLINE</source><creator>Heald, Robert A ; Dexheimer, Thomas S ; Vankayalapati, Hariprasad ; Siddiqui-Jain, Adam ; Szabo, Lajos Z ; Gleason-Guzman, Mary C ; Hurley, Laurence H</creator><creatorcontrib>Heald, Robert A ; Dexheimer, Thomas S ; Vankayalapati, Hariprasad ; Siddiqui-Jain, Adam ; Szabo, Lajos Z ; Gleason-Guzman, Mary C ; Hurley, Laurence H</creatorcontrib><description>The antileukemic xanthone psorospermin is a topoisomerase II−dependent DNA alkylator in advanced preclinical development. Efforts have been made to further understand the structural requirements of its mechanism of action through the synthesis of ring-constrained analogues, based on the skeleton of the bisfuranoxanthone natural products. Molecules were designed that contain the bisfuran and xanthone portions of naturally occurring psorofebrins, and molecular modeling was used to assess their DNA alkylating potential and to refine the structures. A short, diastereoselective synthetic process to access bisfuranoxanthones was developed, culminating in the first total synthesis of (±)-isohydroxypsorofebrin. Two compounds designed and synthesized were of particular interest, chlorohydrin 7 and epoxide 6, which are reactive analogues of the natural product isohydroxypsorofebrin. The chlorohydrin retains the psorospermin-like DNA alkylation characteristics despite its rigid structure and high innate affinity for DNA. Molecular modeling has been used to rationalize the increased activity of the chlorohydrin. The chlorohydrin and epoxide show increased cytotoxicity compared to isohydroxypsorofebrin against a range of human tumor cell lines.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm049299c</identifier><identifier>PMID: 15828838</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Antineoplastic agents ; Antineoplastic Agents, Alkylating - chemical synthesis ; Antineoplastic Agents, Alkylating - chemistry ; Antineoplastic Agents, Alkylating - pharmacology ; Biological and medical sciences ; Cell Line, Tumor ; DNA Topoisomerases, Type II - metabolism ; Drug Design ; Drug Screening Assays, Antitumor ; Furans - chemical synthesis ; Furans - chemistry ; Furans - pharmacology ; General aspects ; Humans ; Medical sciences ; Models, Molecular ; Molecular Conformation ; Pharmacology. Drug treatments ; Stereoisomerism ; Structure-Activity Relationship ; Xanthones - chemical synthesis ; Xanthones - chemistry ; Xanthones - pharmacology</subject><ispartof>Journal of medicinal chemistry, 2005-04, Vol.48 (8), p.2993-3004</ispartof><rights>Copyright © 2005 American Chemical Society</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a381t-193a92135df14408f637d22e3293291f9054688e54a35d0168b50d798e4843da3</citedby><cites>FETCH-LOGICAL-a381t-193a92135df14408f637d22e3293291f9054688e54a35d0168b50d798e4843da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm049299c$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm049299c$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16740259$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15828838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heald, Robert A</creatorcontrib><creatorcontrib>Dexheimer, Thomas S</creatorcontrib><creatorcontrib>Vankayalapati, Hariprasad</creatorcontrib><creatorcontrib>Siddiqui-Jain, Adam</creatorcontrib><creatorcontrib>Szabo, Lajos Z</creatorcontrib><creatorcontrib>Gleason-Guzman, Mary C</creatorcontrib><creatorcontrib>Hurley, Laurence H</creatorcontrib><title>Conformationally Restricted Analogues of Psorospermin:  Design, Synthesis, and Bioactivity of Natural-Product-Related Bisfuranoxanthones</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The antileukemic xanthone psorospermin is a topoisomerase II−dependent DNA alkylator in advanced preclinical development. Efforts have been made to further understand the structural requirements of its mechanism of action through the synthesis of ring-constrained analogues, based on the skeleton of the bisfuranoxanthone natural products. Molecules were designed that contain the bisfuran and xanthone portions of naturally occurring psorofebrins, and molecular modeling was used to assess their DNA alkylating potential and to refine the structures. A short, diastereoselective synthetic process to access bisfuranoxanthones was developed, culminating in the first total synthesis of (±)-isohydroxypsorofebrin. Two compounds designed and synthesized were of particular interest, chlorohydrin 7 and epoxide 6, which are reactive analogues of the natural product isohydroxypsorofebrin. The chlorohydrin retains the psorospermin-like DNA alkylation characteristics despite its rigid structure and high innate affinity for DNA. Molecular modeling has been used to rationalize the increased activity of the chlorohydrin. The chlorohydrin and epoxide show increased cytotoxicity compared to isohydroxypsorofebrin against a range of human tumor cell lines.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents, Alkylating - chemical synthesis</subject><subject>Antineoplastic Agents, Alkylating - chemistry</subject><subject>Antineoplastic Agents, Alkylating - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>DNA Topoisomerases, Type II - metabolism</subject><subject>Drug Design</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Furans - chemical synthesis</subject><subject>Furans - chemistry</subject><subject>Furans - pharmacology</subject><subject>General aspects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Pharmacology. Drug treatments</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Xanthones - chemical synthesis</subject><subject>Xanthones - chemistry</subject><subject>Xanthones - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkc9O3DAQxq2qqGyBQ1-gyqWHSqT1vyR2b7AtFAmVhaWt1Is1JDb1ksQr20HsjSs8Jk-CV7tiL0gjzcjzm0-ebxD6QPAXgin5Ouswl1TK-g0akYLinAvM36IRxpTmtKRsG70PYYYxZoSyd2ibFIIKwcQIPY5db5zvIFrXQ9susgsdord11E12kF7c9aBD5kw2Cc67MNe-s_23p_uH7LsO9rrfz6aLPv5PddjPoG-yQ-ugjvbWxsVy7BfEwUObT7xrhjrmF7qFpfahDSY1encHadz1OuyiLQNt0HvrvIN-H_24HP_MT8-OT8YHpzkwQWJOJANJCSsaQzjHwpSsaijVjMoUxEhc8FIIXXBIDCaluCpwU0mhueCsAbaDPq9067RP8Nqoubcd-IUiWC39VC9-Jvbjip0PV51uNuTawAR8WgMQamhN2qi2YcOVFce0kInLV5wNUd-99MHfqLJiVaEuJ1NF_xxPzqflX_Vvowt1UDM3-HSK8MoHnwEq4ZsQ</recordid><startdate>20050421</startdate><enddate>20050421</enddate><creator>Heald, Robert A</creator><creator>Dexheimer, Thomas S</creator><creator>Vankayalapati, Hariprasad</creator><creator>Siddiqui-Jain, Adam</creator><creator>Szabo, Lajos Z</creator><creator>Gleason-Guzman, Mary C</creator><creator>Hurley, Laurence H</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20050421</creationdate><title>Conformationally Restricted Analogues of Psorospermin:  Design, Synthesis, and Bioactivity of Natural-Product-Related Bisfuranoxanthones</title><author>Heald, Robert A ; Dexheimer, Thomas S ; Vankayalapati, Hariprasad ; Siddiqui-Jain, Adam ; Szabo, Lajos Z ; Gleason-Guzman, Mary C ; Hurley, Laurence H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a381t-193a92135df14408f637d22e3293291f9054688e54a35d0168b50d798e4843da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents, Alkylating - chemical synthesis</topic><topic>Antineoplastic Agents, Alkylating - chemistry</topic><topic>Antineoplastic Agents, Alkylating - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>DNA Topoisomerases, Type II - metabolism</topic><topic>Drug Design</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Furans - chemical synthesis</topic><topic>Furans - chemistry</topic><topic>Furans - pharmacology</topic><topic>General aspects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Pharmacology. Drug treatments</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Xanthones - chemical synthesis</topic><topic>Xanthones - chemistry</topic><topic>Xanthones - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heald, Robert A</creatorcontrib><creatorcontrib>Dexheimer, Thomas S</creatorcontrib><creatorcontrib>Vankayalapati, Hariprasad</creatorcontrib><creatorcontrib>Siddiqui-Jain, Adam</creatorcontrib><creatorcontrib>Szabo, Lajos Z</creatorcontrib><creatorcontrib>Gleason-Guzman, Mary C</creatorcontrib><creatorcontrib>Hurley, Laurence H</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heald, Robert A</au><au>Dexheimer, Thomas S</au><au>Vankayalapati, Hariprasad</au><au>Siddiqui-Jain, Adam</au><au>Szabo, Lajos Z</au><au>Gleason-Guzman, Mary C</au><au>Hurley, Laurence H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conformationally Restricted Analogues of Psorospermin:  Design, Synthesis, and Bioactivity of Natural-Product-Related Bisfuranoxanthones</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2005-04-21</date><risdate>2005</risdate><volume>48</volume><issue>8</issue><spage>2993</spage><epage>3004</epage><pages>2993-3004</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>The antileukemic xanthone psorospermin is a topoisomerase II−dependent DNA alkylator in advanced preclinical development. Efforts have been made to further understand the structural requirements of its mechanism of action through the synthesis of ring-constrained analogues, based on the skeleton of the bisfuranoxanthone natural products. Molecules were designed that contain the bisfuran and xanthone portions of naturally occurring psorofebrins, and molecular modeling was used to assess their DNA alkylating potential and to refine the structures. A short, diastereoselective synthetic process to access bisfuranoxanthones was developed, culminating in the first total synthesis of (±)-isohydroxypsorofebrin. Two compounds designed and synthesized were of particular interest, chlorohydrin 7 and epoxide 6, which are reactive analogues of the natural product isohydroxypsorofebrin. The chlorohydrin retains the psorospermin-like DNA alkylation characteristics despite its rigid structure and high innate affinity for DNA. Molecular modeling has been used to rationalize the increased activity of the chlorohydrin. The chlorohydrin and epoxide show increased cytotoxicity compared to isohydroxypsorofebrin against a range of human tumor cell lines.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>15828838</pmid><doi>10.1021/jm049299c</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2005-04, Vol.48 (8), p.2993-3004
issn 0022-2623
1520-4804
language eng
recordid cdi_crossref_primary_10_1021_jm049299c
source ACS Publications; MEDLINE
subjects Antineoplastic agents
Antineoplastic Agents, Alkylating - chemical synthesis
Antineoplastic Agents, Alkylating - chemistry
Antineoplastic Agents, Alkylating - pharmacology
Biological and medical sciences
Cell Line, Tumor
DNA Topoisomerases, Type II - metabolism
Drug Design
Drug Screening Assays, Antitumor
Furans - chemical synthesis
Furans - chemistry
Furans - pharmacology
General aspects
Humans
Medical sciences
Models, Molecular
Molecular Conformation
Pharmacology. Drug treatments
Stereoisomerism
Structure-Activity Relationship
Xanthones - chemical synthesis
Xanthones - chemistry
Xanthones - pharmacology
title Conformationally Restricted Analogues of Psorospermin:  Design, Synthesis, and Bioactivity of Natural-Product-Related Bisfuranoxanthones
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T20%3A40%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conformationally%20Restricted%20Analogues%20of%20Psorospermin:%E2%80%89%20Design,%20Synthesis,%20and%20Bioactivity%20of%20Natural-Product-Related%20Bisfuranoxanthones&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Heald,%20Robert%20A&rft.date=2005-04-21&rft.volume=48&rft.issue=8&rft.spage=2993&rft.epage=3004&rft.pages=2993-3004&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm049299c&rft_dat=%3Cistex_cross%3Eark_67375_TPS_2VGPQS6W_Z%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15828838&rfr_iscdi=true